STOCK TITAN

Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Biofrontera Inc. received an amended Schedule 13G/A from Rosalind Advisors, Inc., Rosalind Master Fund L.P., and portfolio managers Steven Salamon and Gilad Aharon reporting a significant ownership position in the company’s common shares.

The reporting group may be deemed to beneficially own 1,275,609 common shares, representing approximately 9.96% of Biofrontera’s 12,803,344 common shares outstanding as of May 13, 2026. They also hold preferred shares and convertible debt that would be convertible into an additional 15,526,020 common shares; however, a 9.99% ownership “blocker” provision prevents exercising these instruments to the extent such exercise would push ownership above that threshold, so they state they cannot currently exercise them.

The reporting persons have shared voting and dispositive power over 1,275,609 shares and no sole voting or dispositive power. Rosalind Advisors acts as investment advisor to the fund, and Salamon and Aharon as portfolio managers, but they each disclaim beneficial ownership of shares held by the fund.

Positive

  • None.

Negative

  • None.
Beneficially owned common shares 1,275,609 shares Common stock beneficially owned by Rosalind Master Fund L.P.
Shares outstanding 12,803,344 shares Biofrontera common stock outstanding as of May 13, 2026
Reported ownership percentage 9.9% Percent of Biofrontera common shares reported for each reporting person
Approximate beneficial ownership 9.96% Rosalind Master Fund L.P. beneficial ownership of common stock only
Potential shares from preferred stock 12,545,855 shares Common shares issuable upon exercise of preferred shares
Potential shares from convertible debt 2,980,165 shares Common shares issuable upon exercise of convertible debt
Ownership blocker threshold 9.99% Maximum beneficial ownership allowed before exercise of preferred or debt is blocked
beneficial ownership financial
"may have been deemed to have the beneficial ownership of 1,275,609 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provision financial
"because they contain a blocker provision under which the holder"
convertible debt financial
"shares of Common Stock issuable upon exercise of convertible debt"
A convertible debt is a loan a company takes that gives the lender the option to swap the owed money for a set number of the company’s shares instead of getting cash back. It matters to investors because it can change who owns the company and how much their shares are worth: if lenders convert, existing shareholders can be diluted, but conversion can also signal confidence and reduce a company’s cash pressure — like getting a coupon that can be redeemed for store ownership rather than a refund.
preferred shares financial
"shares of Common Stock issuable upon exercise of preferred shares"
Preferred shares are a type of investment that gives investors priority over common shareholders when it comes to receiving dividends and getting their money back if a company is sold or liquidated. Think of them as a safer, more predictable way to earn income from a company's profits, similar to a fixed-return investment, but without voting rights. This makes preferred shares appealing to those seeking stable income with a higher claim on assets than regular stockholders.
shared voting power financial
"Shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive power financial
"Shared power to dispose or to direct the disposition of"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake in Biofrontera Inc. (BFRI) does Rosalind Master Fund report?

Rosalind Master Fund reports beneficial ownership of 1,275,609 Biofrontera common shares, or about 9.96% of the 12,803,344 shares outstanding as of May 13, 2026, based on the issuer’s May 14, 2026 Form 10-Q.

How many Biofrontera (BFRI) shares could be issued from Rosalind’s preferred and debt holdings?

Rosalind’s position includes 12,545,855 common shares issuable from preferred shares and 2,980,165 from convertible debt, totaling 15,526,020 potential additional shares, separate from the currently counted 1,275,609 common shares.

Why can’t Rosalind currently convert its Biofrontera (BFRI) preferred shares and convertible debt?

The preferred shares and convertible debt contain a 9.99% blocker provision, which prevents exercise if it would result in beneficial ownership above 9.99% of Biofrontera’s common stock, so Rosalind states it cannot currently exercise them.

What voting and dispositive power does Rosalind have over Biofrontera (BFRI) shares?

The reporting persons state they have shared voting and dispositive power over 1,275,609 Biofrontera common shares and no sole voting or dispositive power over any shares as of the reporting date.

How is the 9.9% Biofrontera (BFRI) ownership percentage for Rosalind calculated?

The Schedule 13G/A states each reporting person’s 9.9% or approximately 9.96% ownership is calculated using 12,803,344 Biofrontera common shares outstanding as of May 13, 2026, as disclosed in the issuer’s May 14, 2026 Form 10-Q.

Do Rosalind Advisors and its managers claim beneficial ownership of Biofrontera (BFRI) shares?

Rosalind Advisors, Inc. and portfolio manager Steven Salamon may be deemed beneficial owners of Biofrontera shares held by Rosalind Master Fund, but the filing explicitly states they disclaim beneficial ownership of those shares.





09077D209

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 12,803,344 common stock as of May 13, 2026, as reported in the 10Q filed on May 14, 2026 by the issuer. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 1,275,609 shares of Common Stock 12,545,855 shares of Common Stock issuable upon exercise of preferred shares 2,980,165 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,275,609 shares of Common Stock 12,545,855 shares of Common Stock issuable upon exercise of preferred shares 2,980,165 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,275,609 shares of Common Stock 12,545,855 shares of Common Stock issuable upon exercise of preferred shares 2,980,165 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 1,275,609 shares of Common Stock 12,545,855 shares of Common Stock issuable upon exercise of preferred shares 2,980,165 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:08/12/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/12/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/12/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/12/2026